HDAC9 and Parkinson disease: Despite these successful applications of HDAC inhibitors in cancer treatment, recent studies have shown that the inhibition of histone deacetylases could be extended as a potential way of treating neurodegenerative diseases such as Parkinson’s disease [25,26,27,28,29].